Former GS Institutional Equity Research. Institutional-grade stock picking for retail investors. Focus: Tech, Energy & Alpha generation. Not financial advice.
@StockSavvyShay $ORCL beat earnings, grew OCI 93%, and still got crushed because Wall Street finally wants cash flow instead of another AI spending promise.
This is either a major opportunity or the clearest warning in the AI capex trade.
@RobertA36083266@StockSavvyShay Exactly. If the inflation spike proves mostly energy-driven and temporary, the initial selloff could create some good entries.
Still keeping position sizes reasonable until oil confirms.
@Raaqi88@StockSavvyShay Fair point. With the geopolitical rhetoric escalating, oil cooling in the near term is far from guaranteed.
My point was conditional—if energy rolls over, this PPI spike could fade quickly. Right now that’s still a big “if.”
@KobeissiLetter Ugly headline, but energy did most of the damage.
If oil keeps rolling over, this may end up being peak inflation rather than the start of another lasting wave.
I’ll only say it once.
This might be the fastest way to hit $3 million by the end of 2028:
My June advice:
$PFE (Pfizer) — Don’t buy
$WBD (Warner Bros) — Don’t buy
$FUTU (Futu Holdings) — Don’t buy
$NVDA (Nvidia) → $200 Must buy
$MRVL (Marvell) →$252 Must buy
$SMCI (Super Micro) →$29 Must buy
$QCOM (Qualcomm) →$191 Must buy
$META (Meta Platforms) → $570 Must buy
$MU (Micron Technology) → $891 Must buy
I often get asked why I don’t turn this into paid content, but for me, sharing stock information is just a hobby. I’m not financially struggling, so I choose to share it for free.
@StockSavvyShay Nuclear investing is basically celebrating one regulatory checkbox at a time 😂
Still, every box checked brings Aurora a little closer to producing actual power.
@StockMKTNewz $NVDA is no longer just selling compute to healthcare companies.
It’s helping build the specialized models that could eventually run the entire clinical AI stack.
@StockMKTNewz Which ARK fund do you expect to buy $SPCX?
The Venture Fund already owns it, but it’ll be interesting to see whether ARKK or ARKX receives an IPO allocation.
Yes—that’s the near-term risk, and it has already hurt revenue.
My point isn’t that export controls are bullish by themselves. It’s that they expose how strategically important and supply-constrained InP is.
The thesis only works if $AXTI can secure permits or diversify production and convert the backlog into shipments.
@cryptorover The IPOs aren’t the red flag by themselves.
The red flag is the combination of massive capital needs, extreme valuations and retail being asked to absorb the supply.
@NoLimitGains $QCOM is definitely the laggard from Jensen’s recent callouts.
But the real catalyst isn’t the endorsement—it’s whether Dragonfly and the June 24 investor day can prove Qualcomm has a credible data-center AI business.
This is exactly the kind of second-order SpaceX connection investors should be digging into.
Everyone is chasing the obvious names, while lesser-known suppliers may still be hiding in import data.
$LPK is interesting—but the real questions are:
How large is the contract?
Is the relationship ongoing?
Does it materially impact revenue?
Worth a deeper dive, not a blind chase.
Just thought this was interesting: $LPK is an unknown SpaceX supplier.
You can find it in SpaceX US import logs.
It's fun information discovery ahead of Space'x IPO this week. Though, not sure what the exact contract entails.
Disclosure: I have positions in LPK, NFA, credit to my follower Albert_TheVoid for the DM!
Especially since everyone seems to be talking about about SpaceX with Velo...
Just a fun, new direct relationship between $LPK and SpaceX if people want to do more digging.
@aleabitoreddit Good find and appreciate the disclosure.
The key question is whether SpaceX bought a one-time piece of equipment or whether $LPK has a recurring role in the manufacturing process. That distinction changes the whole thesis.
@aleabitoreddit Funny how the market ignored InP until it started threatening the entire AI optical buildout.
$AXTI may be far more strategically important than its old small-cap label suggests.
@aleabitoreddit The biggest takeaway isn’t the return—it’s the willingness to keep updating the thesis as the market reprices each part of the supply chain.
Conviction matters, but adaptability matters more.
@unusual_whales Competition finally doing its job.
Cheaper AI is great for users, but OpenAI and Anthropic may end up racing each other toward thinner margins.